eMedicine World Medical Library

Excerpt from Status Asthmaticus


Synonyms, Key Words, and Related Terms: status asthmaticus, asthma, asthma treatment, asthma children, acute asthma, hyperactive airway disease, asthma, asthma emergency, allergen exposure, respiratory tract infection, pollen, mold, animal dander, house dust mites, wheezing, chest tightness, progressive shortness of breath, dry cough, viral respiratory illness, underuse of anti-inflammatory therapy, allergic bronchopulmonary aspergillosis, Churg-Strauss vasculitis, beta-agonists, theophylline, bronchoconstrictive response, broncho-constrictive response, peripheral airway inflammation, bronchodilator therapy

Please click here to view the full topic text: Status Asthmaticus

Background

Status asthmaticus is a medical emergency in which asthma symptoms are refractory to initial bronchodilator therapy in the emergency department. Patients report chest tightness, rapidly progressive shortness of breath, dry cough, and wheezing. Typically, patients present a few days after the onset of a viral respiratory illness, following exposure to a potent allergen or irritant, or after exercise in a cold environment. Frequently, patients have underused or have been underprescribed anti-inflammatory therapy. Illicit drug use may play a role in poor adherence to anti-inflammatory therapy. Patients may have increased their beta-agonist intake (either inhaled or nebulized) to as often as every few minutes.

The Medscape Asthma Resource Center may be of interest.

Pathophysiology

Inflammation in asthma is characterized by an influx of eosinophils during the early-phase reaction and a mixed cellular infiltrate composed of eosinophils, mast cells, lymphocytes, and neutrophils during the late-phase (or chronic) reaction. The simple explanation for allergic inflammation in asthma begins with the development of a predominantly helper T2 lymphocyte–driven, as opposed to helper T1 lymphocyte–driven, immune milieu, perhaps caused by certain types of immune stimulation early in life. This is followed by allergen exposure in a genetically susceptible individual.

Specific allergen exposure (eg, dust mites) under the influence of helper T2 lymphocytes leads to B-lymphocyte elaboration of immunoglobulin E (IgE) antibodies specific to that allergen. The IgE antibody attaches to surface receptors on airway mucosal mast cells. One important question is whether atopic individuals with asthma, in contrast to atopic persons without asthma, have a defect in mucosal integrity that makes them susceptible to penetration of allergens into the mucosa.

Subsequent specific allergen exposure leads to cross-bridging of IgE molecules and activation of mast cells, with elaboration and release of a vast array of mediators. These mediators include histamine; leukotrienes C4, D4, and E4; and a host of cytokines. Together, these mediators cause bronchial smooth muscle constriction, vascular leakage, inflammatory cell recruitment (with further mediator release), and mucous gland secretion. These processes lead to airway obstruction by constriction of the smooth muscles, edema of the airways, influx of inflammatory cells, and formation of intraluminal mucus. In addition, ongoing airway inflammation is thought to cause the airway hyperreactivity characteristic of asthma. The more severe the airway obstruction, the more likely ventilation-perfusion mismatching will result in impaired gas exchange and hypoxemia.

Frequency

United States

The prevalence and severity of asthma cases are on the rise (see Asthma). Also increasing are the occurrences of asthma hospitalization and mortality resulting from status asthmaticus. Status asthmaticus is usually more common among persons in low socioeconomic groups, regardless of race, and particularly in people who live alone.

A 2004 study conducted at the Columbia University Medical Center,1 however, noted the number of patients with status asthmaticus requiring intensive care admissions declined over the past 10 years. The trend was toward less advanced presentations. This may reflect improvements in medication compliance, education, or access to medical care.

International

Similar to the US data, asthma mortality rates are increasing.

Mortality/Morbidity

  • Patients who delay medical treatment, particularly treatment with systemic steroids, have a greater chance of dying.
  • Patients with other preexisting conditions (eg, restrictive lung disease, congestive heart failure, chest deformities) are at particular risk of death from status asthmaticus.
  • Patients who smoke regularly have chronic inflammation of the small airways and are at particular risk of death from status asthmaticus.

Race

  • A 1997 study by Hanania et al2 noted that although asthma is more common among African American and Hispanic persons, this prevalence may be the result of socioeconomic factors rather than race.
  • African American and Hispanic persons in the United States, in association with lower socioeconomic factors, have less access to regular specialist medical care, which leads to an increased risk of status asthmaticus.
  • In the United States, particularly in large cities, illiteracy and lower educational competence are more prevalent in African American and Hispanic families, and children in these families have increased morbidity from asthma.

Sex

  • Status asthmaticus is slightly more common in males than in females.

Age

  • Status asthmaticus can occur in persons of any age group, including infants and geriatric patients. Mortality rates are higher in very young children and elderly adults.
  • Children younger than 2 years, and sometimes those older, may have respiratory syncytial virus (RSV) infections that can result in severe attacks of wheezing that mimic status asthmaticus. Also, RSV infections can predispose patients to asthma later in life.

Please click here to view the full topic text: Status Asthmaticus

About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers
Labelled with ICRA © 1996-2006 by WebMD.
All Rights Reserved.

Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER